Daily Stock Analysis, CBIO, Catalyst Biosciences Inc, priceseries

Catalyst Biosciences Inc. Daily Stock Analysis
Stock Information
Open
8.27
Close
8.50
High
8.65
Low
8.15
Previous Close
9.31
Daily Price Gain
-0.81
YTD High
10.84
YTD High Date
Apr 5, 2019
YTD Low
6.92
YTD Low Date
Jun 7, 2019
YTD Price Change
0.25
YTD Gain
3.03%
52 Week High
14.37
52 Week High Date
Jul 16, 2018
52 Week Low
6.20
52 Week Low Date
Dec 24, 2018
52 Week Price Change
-3.94
52 Week Gain
-31.67%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 12. 2017
10.20
Jan 13. 2017
10.85
1 Trading Days
6.37%
Link
LONG
Feb 13. 2017
9.50
Feb 14. 2017
10.16
1 Trading Days
6.95%
Link
LONG
Mar 28. 2017
15.01
Mar 29. 2017
16.55
1 Trading Days
10.29%
Link
LONG
Sep 12. 2017
3.62
Oct 12. 2017
5.29
22 Trading Days
46.16%
Link
LONG
Nov 15. 2017
4.89
Jan 16. 2018
14.46
40 Trading Days
195.73%
Link
LONG
Jan 17. 2018
17.15
Jan 30. 2018
20.88
9 Trading Days
21.77%
Link
LONG
Apr 12. 2018
24.76
May 3. 2018
27.73
15 Trading Days
11.99%
Link
LONG
Mar 11. 2019
8.53
Mar 21. 2019
9.23
8 Trading Days
8.20%
Link
LONG
Apr 1. 2019
8.93
Apr 11. 2019
9.59
8 Trading Days
7.37%
Link
Company Information
Stock Symbol
CBIO
Exchange
NasdaqGS
Company URL
http://www.catalystbiosciences.com
Company Phone
6507450655
CEO
Nassim Usman
Headquarters
California
Business Address
260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA 94080
Sector
-
Industry Category
-
Industry Group
-
CIK
0001124105
About

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on creating and developing novel medicines to address serious medical conditions for patients who need new or better treatment options. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.

Description

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders.